(PharmaNewsWire.Com, December 18, 2017 ) The utilization of metallic drug eluting stents shows some strong disadvantages. These disadvantages are predisposition to late stent thrombosis, hindrance of surgical revascularization, prevention of late vessel expansive or adaptive remodeling and impairment of imaging with multi-slice CT.To overcome some of these potential disadvantages, a few organizations are seeking after the improvement of bioabsorbable stents. Like metal stents, position of a bioresorbable stent will reestablish blood stream and bolster the vessel through the recuperating procedure. In any case, on account of a bioresorbable stent, the stent will slowly resorb and be cleared from the body.
Aging population and increase in the cardiovascular diseases due to factors like are the key driving factors for the growth of the North America bioabsorbable stents market. Positive outcomes of surgeries with bioabsorbable stents and post-surgery reports also account for the development of market. However, there are many regulatory, technological, Safety-efficacy and also cost related issues which market has to deal with before reaching its full potential.
The North America bioabsorbable stents market is segmented into different categories based on material, absorption rate, application and end user. Based on material, bioabsorbable stents can be divided into two types. They are polymer stents, and metallic stents. Polymer stents are expected to grow at a higher CAGR compared to metallic stents. Based on absorption rate, market is segmented into slow absorption rate stents and high absorption rate stents. In 2016, market for slow absorption stents is predicted to be on higher side.
By application, bioabsorbable stents are categorized as coronary artery disease and peripheral artery disease. Coronary artery disease is expected to have larger share than peripheral artery disease. On the basis of end user, market can be segmented into hospitals and cardiac centers. The market share is dominated by hospitals. On the basis of geography, the highest market share holder is Europe, followed by North America.
Some of the major players in North America bioabsorbable stents market are Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A, Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT, Xenogenics Corporation
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
